EMAIL THIS PAGE TO A FRIEND

Nature communications

PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.


PMID 26258887

Abstract

Most tumour cells use aerobic glycolysis (the Warburg effect) to support anabolic growth and evade apoptosis. Intriguingly, the molecular mechanisms that link the Warburg effect with the suppression of apoptosis are not well understood. In this study, using loss-of-function studies in vitro and in vivo, we show that the anti-apoptotic protein poly(ADP-ribose) polymerase (PARP)14 promotes aerobic glycolysis in human hepatocellular carcinoma (HCC) by maintaining low activity of the pyruvate kinase M2 isoform (PKM2), a key regulator of the Warburg effect. Notably, PARP14 is highly expressed in HCC primary tumours and associated with poor patient prognosis. Mechanistically, PARP14 inhibits the pro-apoptotic kinase JNK1, which results in the activation of PKM2 through phosphorylation of Thr365. Moreover, targeting PARP14 enhances the sensitization of HCC cells to anti-HCC agents. Our findings indicate that the PARP14-JNK1-PKM2 regulatory axis is an important determinant for the Warburg effect in tumour cells and provide a mechanistic link between apoptosis and metabolism.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

F3680
10058-F4, ≥98% (HPLC), solid
C12H11NOS2
D8375
2-Deoxy-D-glucose, ≥98% (GC), crystalline
C6H12O5
D6134
2-Deoxy-D-glucose, ≥99% (GC), crystalline
C6H12O5
D3179
2-Deoxy-D-glucose, BioXtra, ≥98%
C6H12O5
HPA012063
Anti-PARP14 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4200094
Anti-PKM2 (isoform M1) antibody produced in rabbit, ~1.5 mg/mL, affinity isolated antibody
N5755
β-Nicotinamide adenine dinucleotide phosphate hydrate
C21H28N7O17P3 · xH2O
N8035
β-Nicotinamide adenine dinucleotide phosphate sodium salt, pkg of 5 mg (per vial)
C21H27N7NaO17P3
N8160
β-Nicotinamide adenine dinucleotide phosphate sodium salt, pkg of 10 mg (per vial)
C21H27N7NaO17P3
658685
Os EnCat® 40, extent of labeling: 0.3 mmol/g Os loading
OsO4
O5500
Osmium tetroxide, Sealed ampule.
O4Os
75632
Osmium tetroxide solution, for electron microscopy, 4% in H2O
O4Os
75633
Osmium tetroxide solution, for electron microscopy, 2% in H2O
O4Os
482749
Trimesic acid, 95%
C9H6O6
257222
Trimethylaluminum, 97%
C3H9Al
663301
Trimethylaluminum, packaged for use in deposition systems
C3H9Al
699020
Trimethylaluminum solution, 2.0 M in chlorobenzene
C3H9Al
379239
Trimethylaluminum solution, 2.0 M in heptane
C3H9Al
268569
Trimethylaluminum solution, 2.0 M in hexanes
C3H9Al
198048
Trimethylaluminum solution, 2.0 M in toluene
C3H9Al